| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of HYPERA SA S/ADR by Hypera SA (OTCID:HYPMY) through any online brokerage.
There are no as such competitors for HYPERA SA S/ADR by Hypera SA.
There is no analysis for HYPERA SA S/ADR by Hypera SA to provide a consensus price target.
The stock price for HYPERA SA S/ADR by Hypera SA (OTCID: HYPMY) is $5.359 last updated October 20, 2026 at 3:37 PM EDT.
There are no upcoming dividends for HYPERA SA S/ADR by Hypera SA.
HYPERA SA S/ADR by Hypera SA does not have any upcoming earnings scheduled.
There is no upcoming split for HYPERA SA S/ADR by Hypera SA.
HYPERA SA S/ADR by Hypera SA is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The...